First-Line Selective Internal Radiation Therapy in Patients with Uveal Melanoma Metastatic to the Liver

Conclusion: First-line SIRT is safe and produced promising outcomes in patients with uveal melanoma metastatic to the liver. Subsequent systemic and liver-directed locoregional therapies ameliorated survival, highlighting the potential for improved outcomes with combination approaches. The results of this study suggest that prospective trials using first-line SIRT should be considered.

Source: Journal of Nuclear Medicine - March 1, 2020 Category: Nuclear Medicine Authors: Ponti, A., Denys, A., Digklia, A., Schaefer, N., Hocquelet, A., Knebel, J.-F., Michielin, O., Dromain, C., Duran, R. Tags: Clinical Source Type: research